Clinical Trial Update: Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing amrubicin with cisplatin to etoposide with cisplatin in extensive-disease small cell lung cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Amrubicin (amrubicin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-07-04